PDL BioPharma, a developer of humanized monoclonal antibodies, has appointed Christine Larson as its new vice president and CFO.
Subscribe to our email newsletter
Previously, Ms Larson served as a senior manager and director at Grant Thornton in their mergers and acquisitions advisory group. Prior to that time, Ms Larson was CFO for TWL Corporation, a publicly held, technology-enabled learning company.
Ms Larson has received a BS in food and nutritional sciences from the University of California, Berkeley, and an MBA from the California State University, East Bay.
John McLaughlin, president and CEO of PDL, said: “Cris began working for PDL in early October on a consulting basis, and we are pleased that she has accepted this key position following today’s completion of the spin-off of our biotechnology assets. Her background in corporate finance and investment banking brings a breadth of experience that furthers our ability to manage our royalty assets and maximize PDL’s return to its stockholders.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.